The 30-s chair stand test can be a useful tool for screening sarcopenia in elderly Japanese participants

Abstract Background Low muscle strength has been focused on as an essential characteristic of sarcopenia, and the 30-s chair stand test (CS-30) could be a particularly useful test for assessing muscle strength. While it is speculated to be a beneficial tool for the assessment of sarcopenia, this rem...

Full description

Bibliographic Details
Main Authors: Shuji Sawada, Hayao Ozaki, Toshiharu Natsume, Pengyu Deng, Toshinori Yoshihara, Takashi Nakagata, Takuya Osawa, Yoshihiko Ishihara, Tomoharu Kitada, Ken Kimura, Nobuhiro Sato, Shuichi Machida, Hisashi Naito
Format: Article
Language:English
Published: BMC 2021-07-01
Series:BMC Musculoskeletal Disorders
Subjects:
Online Access:https://doi.org/10.1186/s12891-021-04524-x
Description
Summary:Abstract Background Low muscle strength has been focused on as an essential characteristic of sarcopenia, and the 30-s chair stand test (CS-30) could be a particularly useful test for assessing muscle strength. While it is speculated to be a beneficial tool for the assessment of sarcopenia, this remains to be verified. In this study, we examined the reliability and optimal diagnostic score of the CS-30 for assessing sarcopenia in elderly Japanese participants. Methods This cross-sectional study included 678 participants (443 females and 235 males) who underwent the test for sarcopenia as per the Asian Working Group for Sarcopenia (AWGS) 2019, the CS-30 test, and the isometric knee-extension muscle strength test. ROC analysis was used to estimate the optimal CS-30 scores at which sarcopenia was detected. Results CS-30 scores were positively associated with sarcopenia (OR: 0.88; 95% CI:0.82–0.93). The AUC of the CS-30 for sarcopenia definition were 0.84 (p < 0.001) for females and 0.80 (p < 0.001) for males. The optimal number of stands in the CS-30 that predicted sarcopenia was 15 for females (sensitivity, 76.4%; specificity, 76.8%) and 17 for males (sensitivity, 75.0%; specificity, 71.7%). Conclusions The CS-30 was found to be a reliable test for sarcopenia screening in the elderly Japanese population.
ISSN:1471-2474